SUBCUTANEOUS HEPARIN DOSE IN UNDERWEIGHT CRITICALLY ILL PATIENTS

被引:0
|
作者
Lee, Bernice [1 ]
Ammar, Abdalla [2 ]
Sakya, Sagune [3 ]
Spitler, Flint [4 ]
Tran, Lydia [5 ]
Ammar, Mahmoud [5 ]
机构
[1] Yale New Haven Hosp, 20 York St, New Haven, CT 06504 USA
[2] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA
[3] Yale New Haven Hlth Hosp, New Haven, CT USA
[4] Bridgeport Hosp, Bridgeport, CT USA
[5] Yale New Haven Hosp, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
41
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [1] EVALUATING APTT PROLONGATION WITH HEPARIN THROMBOPROPHYLAXIS IN UNDERWEIGHT CRITICALLY ILL PATIENTS
    Kumar, Pooja
    Ammar, Abdalla
    Dumitru, Roxana
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [2] DRUG USAGE EVALUATION OF LOW-DOSE SUBCUTANEOUS HEPARIN-PROPHYLAXIS IN CRITICALLY ILL PATIENTS
    MIWA, LJ
    SHAEFER, MS
    WULF, BG
    [J]. HOSPITAL FORMULARY, 1990, 25 (03): : 306 - 309
  • [3] COMPARATIVE BIOACTIVITY OF SUBCUTANEOUS HEPARIN IN CRITICALLY ILL PATIENTS WITH NORMAL RENAL FUNCTION
    Gouya, G.
    Palkovits, S.
    Kapiotis, S.
    Madl, C.
    Locker, G.
    Stella, A.
    Wolzt, M.
    Heinz, G.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 112 - 112
  • [4] Nutritional therapy and outcomes in underweight critically ill patients
    Viana, Marina V.
    Tavares, Ana Laura
    Gross, Luiza A.
    Tonietto, Tiago Antonio
    Costa, Vicente L.
    Moraes, Rafael B.
    Azevedo, Mirela J.
    Viana, Luciana V.
    [J]. CLINICAL NUTRITION, 2020, 39 (03) : 935 - 941
  • [5] Continuation of therapeutic dose heparin for critically ill patients with COVID-19
    Bradbury, Charlotte A.
    Lawler, Patrick R.
    McVerry, Bryan J.
    Zarychanski, Ryan
    REMAP C A P Investigators
    [J]. INTENSIVE CARE MEDICINE, 2023, 49 (07) : 873 - 875
  • [6] Continuation of therapeutic dose heparin for critically ill patients with COVID-19
    Charlotte A. Bradbury
    Patrick R. Lawler
    Bryan J. McVerry
    Ryan Zarychanski
    [J]. Intensive Care Medicine, 2023, 49 : 873 - 875
  • [7] CHARACTERIZATION OF HEPARIN DOSE RESPONSE BY WEIGHT FOR VTE PROPHYLAXIS IN CRITICALLY ILL PATIENTS
    Aggarwal, Meera
    Jarrell, Andrew
    Gilmore, Vi
    Aboagye, Jonathan
    Haut, Elliott
    Hobson, Deborah
    Lau, Brandyn
    Kickler, Thomas
    Kraus, Peggy
    Shaffer, Dauryne
    Shermock, Kenneth
    Streiff, Michael
    Zheng, Gang
    Kruer, Rachel
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [8] PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS IN UNDERWEIGHT CRITICALLY ILL PATIENTS
    Kuriyama, Akira
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [9] UFH DOSE BASED ON EBV AS A PREDICTOR OF VTE AND BLEEDING IN THE UNDERWEIGHT AND CRITICALLY ILL
    Carter, Chris
    Betthauser, Kevin
    Peppard, William
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [10] Monitoring of unfractionated heparin in critically ill patients
    Aarab, R.
    van Es, J.
    de Pont, A. C. J. M.
    Vroom, M. B.
    Middeldorp, S.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (09): : 466 - 471